National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

CC-4047

 A substance being studied in the treatment of prostate cancer, multiple myeloma, and other types of cancer. CC-4047 is a form of the drug thalidomide. It stops the growth of blood vessels, stimulates the immune system, and may kill cancer cells. CC-4047 is a type of angiogenesis inhibitor and a type of immunomodulatory agent. Also called Actimid and pomalidomide.



Previous Definitions:CBC, CBE, cBR96-doxorubicin immunoconjugate, CBT-1, CC-1088
Next Definitions:CC-49, CC-5013, CC-8490, CC49-streptavidin, CCI-779

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov